Literature DB >> 31082429

Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.

Xiao Juan Tang1, Wei Wang2, Swei Sunny Hann3.   

Abstract

Long non-coding RNAs (lncRNAs) are longer than 200 nts non-coding transcripts and have recently emerged as one of the largest and significantly diverse RNA families whereas microRNAs (miRNAs) are highly conserved short single-stranded ncRNAs (∼18-22 nucleotides). As families of small and long evolutionarily conserved ncRNAs, lncRNAs activate and repress genes via a variety of mechanisms at both transcriptional and translational levels, while miRNAs regulate protein-coding gene expression mainly through mRNA degradation or silencing, These ncRNAs have been proved to be involved in multiple biological functions, such as proliferation, differentiation, migration, angiogenesis and apoptosis. Today, while majority of studies have focused on defining the regulatory functions of lncRNAs and miRNAs, limited information have now available for the mutual regulations of lncRNAs, miRNAs and mRNA. Thus, the underlying molecular mechanisms, in particularly the interactions among lncRNAs, miRNAs and mRNA in development, growth, metastasis and therapeutic potential of cancer still remain obscure. Colorectal cancer (CRC) is known as the third most common and fourth leading cancer death worldwide. Increasing evidence showed the close correlations among aberrant expressions of lncRNAs, miRNAs and the occurrence, development of CRC. This review summarize the potential links among these RNAs in following three areas: 1, The biogenesis and roles of miRNAs in CRC; 2, The biogenesis and functions of lncRNAs in CRC; 3, The interactions among lncRNAs, miRNAs and mRNA in tumorigensis, growth, progression, EMT formation, chemoradiotherapy resistance, and therapeutic potential in CRC. We believe that identifying diverging lncRNAs, miRNAs and relevant genes, their interactions and complex molecular regulatory networks will provide important clues for understanding the mechanism and developing novel diagnostic and therapeutic strategies for CRC. Further efforts are warranted to bring the promise of regulating their activities into clinical utilities.
Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Biomarkers; Colorectal cancer; LncRNAs; MRNA; MiRNA; Therapeutics

Mesh:

Substances:

Year:  2019        PMID: 31082429     DOI: 10.1016/j.biochi.2019.05.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  37 in total

1.  LncRNA GAS5 regulates migration and epithelial-to-mesenchymal transition in lens epithelial cells via the miR-204-3p/TGFBR1 axis.

Authors:  Xiao Li; Miaomiao Sun; Anran Cheng; Guangying Zheng
Journal:  Lab Invest       Date:  2021-12-16       Impact factor: 5.662

2.  M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling.

Authors:  Jian-Qing Chen; Yuan-Ping Tao; Yong-Gang Hong; Hui-Fen Li; Zhi-Ping Huang; Xuan-Fu Xu; Hao Zheng; Liang-Kai Hu
Journal:  Cell Cycle       Date:  2021-10-17       Impact factor: 5.173

3.  miR-122 and miR-197 expressions in hepatic carcinoma patients before and after chemotherapy and their effect on patient prognosis.

Authors:  Gang Zhan; Hui Jiang; Rui Yang; Kai Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway.

Authors:  Faming Wang; Yao Luo; Le Zhang; Muhammad Younis; Liudi Yuan
Journal:  Cancer Gene Ther       Date:  2021-03-11       Impact factor: 5.987

5.  Knockdown of lncRNA HCP5 Suppresses the Progression of Colorectal Cancer by miR-299-3p/PFN1/AKT Axis.

Authors:  Ni Bai; Ying Ma; Jia Zhao; Bo Li
Journal:  Cancer Manag Res       Date:  2020-06-19       Impact factor: 3.989

6.  YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2.

Authors:  Zhen Yang; Hongjian Ding; Zhiyu Pan; Huaqing Li; Junbin Ding; Qian Chen
Journal:  Cancer Biol Ther       Date:  2021-03-08       Impact factor: 4.742

7.  The miR-106b/NR2F2-AS1/PLEKHO2 Axis Regulates Migration and Invasion of Colorectal Cancer through the MAPK Pathway.

Authors:  Shuzhen Liu; Guoyan An; Qing Cao; Tong Li; Xinyu Jia; Lei Lei
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

8.  Long Non-coding RNA MIR570MG Causes Regorafenib Resistance in Colon Cancer by Repressing miR-145/SMAD3 Signaling.

Authors:  Fang Wei; Mofei Wang; Zhen Li; Yong Wang; Yong Zhou
Journal:  Front Oncol       Date:  2020-03-05       Impact factor: 6.244

9.  Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression.

Authors:  Qi Chen; Hui Yang; Xiaolan Zhu; Shangwan Xiong; Huamao Chi; Wenlin Xu
Journal:  Front Genet       Date:  2020-05-29       Impact factor: 4.599

10.  Expression levels and associations of five long non-coding RNAs in gastric cancer and their clinical significance.

Authors:  Helen Barong Binang; Yun-Shan Wang; Marlvin Anemey Tewara; Lutao Du; Shuang Shi; Ning Li; Ariston Gabriel Abakundana Nsenga; Chuanxin Wang
Journal:  Oncol Lett       Date:  2020-01-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.